Surgical site infections (SSIs) are the most common types of healthcare-associated infections (HAIs). These infections lead to longer hospital stays, and the patients may require additional surgical procedures and intensive care. The risks associated with SSIs often lead to morbidity and mortality, owing to which healthcare professionals across the world are using SSI products. Thus, the rising cases of SSIs will boost the adoption of such products in healthcare facilities. For instance, according to the European Center for Disease Prevention and Control (ECDC), around 543,149 SSI cases are reported annually in the European Union (EU) nations.
At present, hospitals, ambulatory surgery centers (ASCs), and clinics are using clippers, surgical drapes, patient-warming products, surgical staff clothing, wound care supplementary products, wound irrigation products, wound care dressings, antibiotic prophylaxis products, and antiseptics and disinfectants, to prevent SSIs. In the past, antibiotic prophylaxis products were adopted in the highest quantity to avoid infection and contamination during the course of treatment. Whereas, in the coming years, antiseptics and disinfectants will be consumed at the highest pace, due to the increasing incidence of SSIs, worldwide.
Browse report with detailed COVID-19 impact analysis on Surgical Site Infection Market Competitive Landscape Report
According to P&S Intelligence, North America adopted the highest quantity of SSI prevention products in 2017, owing to the presence of developed healthcare infrastructure, subsequent surge in number of surgical procedures, and strong presence of prominent SSI product manufacturers, in the region. Additionally, the booming elderly population and mounting public awareness about SSIs are also fueling the need for SSI products in North America. As per the World Bank, nearly 18% and 17% of the population of Canada and the U.S., respectively, were aged 65 years and above in 2020.
Whereas, the Asia-Pacific (APAC) surgical site infection market is expected to display the fastest growth throughout the forecast period. This will be due to the surging geriatric population, rising prevalence of SSIs, developing healthcare infrastructure, and increasing adoption of technologically advanced products. For instance, the United Nations Population Fund (UNFPA) forecasts that the population of people above 60 years of age in APAC will reach around 1.3 billion by 2050. Therefore, by 2050, one in four people in the region will be over 60 years old.
Surgical Site Infection Control Market Report: Information by Product (Disinfectants, Surgical Scrubs), Procedure (Cataract Surgery, Caesarean Section), Type of Infection (Superficial Incisional SSI, Deep Incisional SSI)—Global Forecast till 2023The Surgical Site Infection Control Market report offers insights into the leading market players and presents an assessment of their current market position.
Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M activities, and the latest R initiatives is also available in the reportMajor Key PlayersThe key strategies followed by the players operating in the global Surgical Site Infection Control Market were innovation, product development, acquisition, and expansion.3M, Becton Dickinson and Company, Belimed AG, bioMerieux SA, Getinge Group, Johnson & Johnson, Kimberly-Clark Corporation, Sotera Health, Ansell Limited, Steris Corporation, Lac-Mac Limited, Pacon Manufacturing Corp, American Polyfilm Inc., and others.
Market Segment AnalysisGlobal Surgical Site Infection Control Market, by ProductManual Reprocessors SolutionDisinfectantsHand DisinfectantsSkin DisinfectantsSurgical ScrubsSurgical DrapesSkin Preparation SolutionMedical NonwovensSurgical GlovesOthersGlobal Surgical Site Infection Control Market, by ProcedureCataract SurgeryCesarean SectionDental RestorationGastric BypassOthersGlobal Surgical Site Infection Control Market, by Type of InfectionSuperficial Incisional SSIDeep Incisional SSIOrgan or Space SSI Top of FormKey Study Highlights:This report for Surgical Site Infection Control Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance.The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.
The report also gives a broad study of the different market segments and regions.Regional AnalysisGeographically, the global Surgical Site Infection Control Market has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.Browse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/surgical-site-infection-control-market-7830Chapter 9.
Global Surgical Site Infection Control Market By Region9.1 Introduction9.2 America9.2.1 North America9.2.1.1 U.S.9.2.1.2 Canada9.2.2 South America9.3 Europe9.3.1 Western Europe9.3.1.1 Germany9.3.1.2 France9.3.1.3 Italy9.3.1.4 Spain9.3.1.5 U.K.9.3.1.6 Rest Of Western Europe9.3.2 Eastern Europe9.4 Asia Pacific9.4.1 Japan9.4.2 China9.4.3 India9.4.4 Australia9.4.5 Republic Of Korea9.4.6 Rest Of Asia Pacific9.5 The Middle East & Africa9.5.1 United Arab Emirates9.5.2 Saudi Arabia9.5.3 Oman9.5.4 Kuwait9.5.5 Qatar9.5.6 Rest Of The Middle East & AfricaAbout Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
The antibiotics Neomycin, Polymyxin B, and Bacitracin are combined as Neosporin Powder 10gm.
Externally, this powder is used for skin problems that have a superficial bacterial infection or are likely to have a bacterial infection.
It is used to prevent infection in open wounds, cuts, minor burns, and surgical wounds.
